Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research
November 19, 2024
San Jose, California — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for infectious disease research. Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System. The SmartChip ND [...]
November 19, 2024
Integral Molecular, a leader in antibody discovery and characterization, has been awarded $2.7 million by the NIH Commercialization Readiness Pilot (CRP) Program. This funding will support FDA-qualification of Integral Molecular’s Membrane Proteome Array™ (MPA), a next-generation technology that provides critical safety data required for Investigational New Drug (IND) filings of biologic drugs. The MPA is [...]
L7 Informatics Partners with ZAETHER to Accelerate Digital Transformation in Life Sciences
November 19, 2024
Strategic Alliance Combines L7’s Unifying Platform with ZAETHER’s Consulting Expertise to Drive Innovation and Operational Excellence AUSTIN, Texas — L7 Informatics, the provider of the leading unifying platform for integrated data and workflow solutions in the life sciences industry, is pleased to announce a strategic partnership with ZAETHER, a renowned enterprise business transformation consultant and industry [...]
Shimadzu Invests in Sepragen Corporation
November 19, 2024
New Venture into Pharmaceutical Manufacturing Supports Business through the Sales of Bioprocess Chromatography Systems UNION CITY, Calif. -- Sepragen Corporation announced that it has entered into a strategic partnership agreement with Shimadzu Corporation of Japan. Sepragen Corporation, with headquarters in Union City, California, is a leading company specializing in the manufacturing and sales of innovative [...]
Labbit LIMS Enhances Commitment to Data Security and Privacy with SOC 2 Type II Certification
November 19, 2024
VICTORIA, BC - Semaphore Solutions, creator of Labbit and a leader in laboratory informatics solutions, is excited to announce the successful completion of its System and Organization Controls 2 (SOC 2) Type II audit. SOC 2 is a standard developed by the American Institute of Certified Public Accounts (AICPA). Attainment of certification with SOC 2 Type II indicates Semaphore [...]
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
November 19, 2024
Launch of new application enables global access to highly recognized solid tumor profiling assay Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the Association for Molecular Pathology (AMP) Annual Meeting. This innovative solution provides [...]
Cytomos secures £5M to scale up production of cell-analysis technology
November 19, 2024
The oversubscribed funding round was led by existing investors Archangels with participation from Old College Capital, Scottish Enterprise and British Business Bank. New investment will allow Cytomos to drive sales of its first commercial product, Celledonia™, built on its cell-analysis technology platform AuraCyt, which is already generating significant market traction. Celledonia™ is a benchtop cell analyser [...]
November 19, 2024
The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level SAN DIEGO -- Scale Biosciences (Scale Bio TM ), a leader in innovative and scalable single cell analysis solutions, and Revvity’s (NYSE: RVTY) BioLegend business, a leading provider of world-class biological reagents and tools, today [...]
November 19, 2024
LONDON – Titian Software (“Titian”), a market leader in life sciences sample management software, today announced that Griffith University’s Compounds Australia, Australia’s only dedicated compound management facility, has selected Titian’s Mosaic Sample Management platform (“Mosaic”) to manage their extensive compound collection and support future growth. Mosaic will enable optimisation of workflow efficiencies at Compounds Australia, [...]
Illumina announces expansion of TruSight Oncology portfolio
November 19, 2024
The latest solution to enable comprehensive genomic profiling of tumors will be presented at the annual meeting of the Association of Molecular Pathology Customer-led research and presentations at the conference will deliver the latest evidence and education in tumor profiling SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that [...]

